COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours Blue Cap AG: Major shareholder PartnerFonds creates basis for further progress in the realization of the Blue Cap share package PartnerFonds AG i.L. plans share exchange offer with Blue Cap AG at fair value, progressing liquidation process. Stable shareholder base confirmed by anchor investors Blue Cap AG Liquidation Process Share Exchange Offer PartnerFonds AG Anchor Investors
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours ATOSS Software SE: Successful start to the year in the first quarter of 2025 with continuous double-digit growth ATOSS Software SE reports successful first quarter results for 2025 with 11% revenue growth driven by cloud and subscription services. Management forecasts around EUR 190 million revenue for 2025 Revenue Growth Cloud Services First Quarter ATOSS Software SE 2025 Forecast
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours SoftwareOne publishes agenda for ordinary Annual General Meeting SoftwareOne Holding AG publishes agenda for ordinary Annual General Meeting with proposals for dividend approval and new Chairman election. Meeting to be held on 16 May 2025 in Lucerne Annual General Meeting Dividend Switzerland SoftwareOne Chairman Election
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours Nordex Group enters 2025 on a strong footing with improved margins, positive free cash flow and confirmation of full year guidance Nordex Group posts solid financial performance in Q1 2025 with improved margins and positive free cash flow, aiming to achieve full year targets Financial Performance EBITDA Margin Free Cash Flow Nordex Group Q1 2025
COMMUNIQUÉ RÉGLEMENTÉ publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours Safran publie son chiffre d’affaires du 1er trimestre 2025 Safran publie un chiffre d'affaires en forte croissance au 1er trimestre 2025, notamment dans l'aéronautique civile et de défense. Perspectives confirmées pour 2025, hors impact des droits de douane Chiffre D'affaires Croissance Safran Defense Aéronautique
COMMUNIQUÉ RÉGLEMENTÉ publié le 25/04/2025 à 07:00, il y a 8 mois 27 jours Safran reports first quarter 2025 revenue Safran reports 16.7% revenue growth in Q1 2025, reaching €7,257 million. Strong momentum in civil aerospace and defense sectors. FY 2025 outlook confirmed, excluding potential impact of tariffs Safran Revenue Growth Defense Q1 2025 Civil Aerospace
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 06:30, il y a 8 mois 27 jours Good start to the year Holcim Group Services Ltd reports stable net sales of CHF 5,544 million in Q1 2025, with over-proportional recurring EBIT growth and M&A momentum. Amrize spin-off on track for June 2025 listing. Full-year guidance confirmed Net Sales Holcim Recurring EBIT Amrize Spin-off M&A Momentum
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 02:05, il y a 8 mois 27 jours Kidoz Inc. : 2024 Record Adjusted EBITDA of USD $1,134,503 (CAD $1,554,963) and Revenue of USD $14,004,527 (CAD $19,194,773) Kidoz Inc. announces audited financial results for 2024, showcasing increased revenue and net income. CEO Jason Williams highlights importance of privacy-first technology in driving growth Revenue Net Income Kidoz Inc. Audited Financial Results Privacy-first Technology
COMMUNIQUÉ DE PRESSE publié le 25/04/2025 à 00:00, il y a 8 mois 27 jours Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
Publié le 22/01/2026 à 07:00, il y a 7 minutes 2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Publié le 22/01/2026 à 07:00, il y a 7 minutes Chiffre d'affaires 2025 : 918 M€ à devises constantes (+4.3%) - 899 M€ à devises courantes (+2.1%)
Publié le 21/01/2026 à 18:07, il y a 13 heures Modalités de mise à disposition des documents préparatoires à l'Assemblée générale mixte du 5 février 2026
Publié le 21/01/2026 à 17:40, il y a 13 heures 27 minutes Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Publié le 22/01/2026 à 05:25, il y a 1 heure 42 minutes Sceptre Ventures Announces 10-for-1 Share Consolidation and Non-Brokered Private Placement Offering
Publié le 22/01/2026 à 00:00, il y a 7 heures 7 minutes Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
Publié le 22/01/2026 à 00:00, il y a 7 heures 7 minutes FutureGen Industries Provides Shareholder Update on Expanded Investment Strategy in High-Growth Technology Sectors
Publié le 21/01/2026 à 23:30, il y a 7 heures 37 minutes Galway Metals Reports Robust PEA Results with 33% and 61% After Tax IRR, Using both Long Term and Spot Pricing Scenarios, Respectively
Publié le 22/01/2026 à 06:40, il y a 27 minutes Galenica continues to grow: sales increase to over CHF 4 billion
Publié le 22/01/2026 à 06:40, il y a 27 minutes Galenica poursuit sur la voie de la croissance: son chiffre d’affaires dépasse les 4 milliards de francs
Publié le 22/01/2026 à 06:05, il y a 1 heure 2 minutes TUMI UNVEILS THE NEXT GENERATION OF THE TUMI ALPHA COLLECTION WITH CAMPAIGNS STARRING LANDO NORRIS AND WEI DAXUN
Publié le 22/01/2026 à 06:00, il y a 1 heure 7 minutes Fewer orders and lower sales - US tariffs, currency effects and cost pressure weigh on earnings